4SC AGの企業価値
4SC AGの企業価値は何ですか。
4SC AGの企業価値は-12.03$です。
企業価値の定義は何ですか。
企業価値は、企業の総市場価値の尺度です。これは、負債、少数株主持分および優先株式から現金および現金同等物を差し引いた時価総額として計算されます。
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
XETRAのセクタHealth Careにおける企業価値の企業と比べる4SC AG
4SC AGは何をしますか。
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
4SC AGと類似の企業価値
- Hydraulique P.B Societe anonymeの企業価値は-12.42$です。
- Brand Architekts plcの企業価値は-12.30$です。
- Ocean Line Port Developmentの企業価値は-12.28$です。
- Neptune Wellness Solutionsの企業価値は-12.24$です。
- Wisdom Sportsの企業価値は-12.18$です。
- Orphazyme A/Sの企業価値は-12.12$です。
- 4SC AGの企業価値は-12.03$です。
- Trilogy International Partnersの企業価値は-12.02$です。
- Watchstone Plcの企業価値は-11.75$です。
- 360 Ludashiの企業価値は-11.41$です。
- KOALAの企業価値は-11.26$です。
- Sing Tao Newsの企業価値は-11.07$です。
- Amuseの企業価値は-10.86$です。